What's new

Human medicines European public assessment report (EPAR): Roclanda, latanoprost / netarsudil, Date of authorisation: 07/01/2021, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Roclanda, latanoprost / netarsudil, Date of authorisation: 07/01/2021, Revision: 8, Status: Authorised

Apr 4, 2025 - 15:33
 0
Human medicines European public assessment report (EPAR): Roclanda, latanoprost / netarsudil, Date of authorisation: 07/01/2021, Revision: 8, Status: Authorised
Human medicines European public assessment report (EPAR): Roclanda, latanoprost / netarsudil, Date of authorisation: 07/01/2021, Revision: 8, Status: Authorised
Read More

Tags:

Previous Article

F-star charts new path, splitting from invoX after 2023’s $161M acquisition

Next Article

Grain-Boundary-Rich Cathode Enabling Fast Ion Diffusion Kinetics for Low-Tempera...

Related Posts

Data Analysis and Real World Interrogation Network (DARWIN EU)

Data Analysis and Real World Interrogation Network (DAR...

Feb 20, 2025  0

Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Krka d.d., emtricitabine,tenofovir disoproxil, Date of authorisation: 28/04/2017, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0

Questions and answers clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - March 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 25 March 2025, 11:00 (CET) to 25 March 2025, 12:00 (CET)

Questions and answers clinic on Product Management Serv...

Mar 7, 2025  0